For Immediate Release
Virufy Beta App Launched in Colombia, Providing At-Home COVID-19 Detection to 4,500 Users
Bogotá, Colombia – February 10, 2023 – Virufy, a cutting-edge smartphone app promising at-home COVID-19 diagnosis, has officially launched its private beta release in Colombia. The app is currently being utilized by 4,500 employees of a major medical insurance and diagnostics company. This technological advancement represents a significant step forward in accessible healthcare, allowing individuals to conveniently and safely monitor their COVID-19 status.
“Virufy is an incredible tool to help protect the health of our patients”, says Dr. James, Chief Legal Officer at the company.
The Virufy app leverages cutting-edge deep learning technology, including audio signal processing and spectrogram/MFCC processing, to classify patient forced cough and breathing samples for COVID-19 disease presence. This beta phase will allow Virufy to gather user feedback and optimize the app for wider distribution.
Virufy is poised to revolutionize how individuals manage their health, particularly during a public health crisis. The app's accessibility and convenience empowers users to take proactive steps towards protecting themselves and their communities.
About Virufy:
Virufy is a robust 501(c)(3) nonprofit company with 250 volunteers/staff and 50 partner organizations including AWS, Pillsbury Law, and One Young World. We've developed a smartphone app which leverages AI to analyze the signature of recorded coughs to determine their similarity to COVID-19 and other diseases. Virufy is supported by faculty and alumni from Harvard, Stanford, UC Berkeley, MIT, and CMU.